GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sai Life Sciences SAILIFE.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

1,836.80

+2.90%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹21.92bn

FY2022FY2026

Net income

₹3.49bn

FY2022FY2026

Free cash flow

−₹721.3m

FY2022FY2026

Shareholders' equity

₹24.84bn

FY2022FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022
Revenue₹21.92bn₹16.96bn₹14.56bn₹11.97bn₹8.69bn
Gross profit₹7.72bn₹6.19bn₹4.88bn₹3.18bn₹2.67bn
Operating income₹5.05bn₹2.73bn₹1.81bn₹768.3m₹558.2m
Net income₹3.49bn₹1.70bn₹828.1m₹99.9m₹62.3m
Diluted earnings per share16.287.984.370.470.29

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022
Total assets₹36.26bn₹31.60bn₹22.75bn₹21.87bn₹21.64bn
Cash and short-term investments₹1.58bn₹3.72bn———
Total liabilities₹11.42bn₹10.32bn₹13.00bn₹12.99bn₹12.86bn
Debt₹2.88bn₹3.52bn₹2.77bn₹2.61bn₹2.97bn
Shareholders' equity₹24.84bn₹21.28bn₹9.75bn₹8.88bn₹8.79bn
Shares outstanding214m213m190m214m214m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022
Cash from operations₹5.21bn₹2.77bn₹2.63bn₹2.19bn₹1.05bn
Capital spending−₹5.93bn−₹3.69bn−₹1.82bn−₹1.13bn−₹2.07bn
Free cash flow−₹721.3m−₹918.4m₹814.0m₹1.06bn−₹1.02bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹5.54bn₹6.02bn₹5.56bn₹5.37bn₹4.96bn₹5.45bn₹4.40bn₹3.92bn
Gross profit₹1.84bn₹2.08bn₹2.11bn₹1.95bn₹1.95bn₹2.00bn₹1.86bn₹1.35bn
Operating income₹1.02bn₹1.31bn₹1.44bn₹1.06bn₹832.1m₹1.26bn₹856.6m₹686.7m
Net income₹732.9m₹1.04bn₹1.00bn₹838.4m₹604.5m₹882.7m₹538.5m₹415.1m
Diluted earnings per share3.424.864.713.932.844.142.842.19
Cash from operations———₹928.0m—₹2.13bn——
Capital spending———−₹2.48bn—−₹2.56bn——
Free cash flow———−₹1.55bn—−₹431.0m——
Total assets—₹36.26bn—₹33.32bn—₹31.60bn—₹24.77bn
Cash and short-term investments₹1.58bn₹1.58bn₹3.06bn₹3.06bn—₹3.72bn—₹2.12bn
Debt—₹1.61bn—₹2.72bn—₹1.88bn—₹8.20bn
Shareholders' equity₹24.84bn₹24.84bn₹22.70bn₹22.70bn—₹21.28bn—₹10.46bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue24.1%——
Operating income87.4%——
Net income226.9%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin35.8%33.6%——

Valuation history

At each fiscal year end

FY2026FY2025FY2024
Price to earnings96.9113.9172.0
Price to sales15.812.010.4

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.